Evidence map›Paper›PMID 21654153›Full record

ArticlePublic health genomics2012

Motivations and perceptions of early adopters of personalized genomics: perspectives from research participants.

S E Gollust, E S Gordon, C Zayac, G Griffin, M F Christman, R E Pyeritz, L Wawak, B A Bernhardt

Abstract read
In one paragraph

Article in Public health genomics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 95 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
95citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

95 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Public knowledge of and attitudes toward genetics and genetic testing.Genetic testing and molecular biomarkers · 2013
    Trial
  9. Review
  10. Article
  11. Article
  12. Article
  13. Attitudes, knowledge, and risk perceptions of patients who received elective genomic testing as a clinical service.Genetics in medicine : official journal of the American College of Medical Genetics · 2024
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

35 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

S E GollustDivision of Health Policy and Management, University of Minnesota School of Public Health, Minneapolis, MN, USA. sgollust@umn.edu
E S Gordon
C Zayac
G Griffin
M F Christman
R E Pyeritz
L Wawak
B A Bernhardt

Funding

Penn Center for ELSI Research in Emerging Genetic Technologies in Health CareP50HG004487 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI PYERITZ, REED E · 2007 to 2012
$6.2M
Assessing Attitudes and Experiences of Early Adopters of Personalized GenomicsRC1HG005369 · NHGRI · UNIVERSITY OF PENNSYLVANIA · PI BERNHARDT, BARBARA A. · 2009 to 2010
$647k
NHGRI NIH HHS 1-P50HG004487-01NHGRI NIH HHS 1RC1HG005369-01NHGRI NIH HHS P50 HG004487NHGRI NIH HHS RC1 HG005369
6 · The paper itself

Abstract

BACKGROUND/

aimsTo predict the potential public health impact of personal genomics, empirical research on public perceptions of these services is needed. In this study, 'early adopters' of personal genomics were surveyed to assess their motivations, perceptions and intentions.

methodsParticipants were recruited from everyone who registered to attend an enrollment event for the Coriell Personalized Medicine Collaborative, a United States-based (Camden, N.J.) research study of the utility of personalized medicine, between March 31, 2009 and April 1, 2010 (n = 369). Participants completed an Internet-based survey about their motivations, awareness of personalized medicine, perceptions of study risks and benefits, and intentions to share results with health care providers.

resultsRespondents were motivated to participate for their own curiosity and to find out their disease risk to improve their health. Fewer than 10% expressed deterministic perspectives about genetic risk, but 32% had misperceptions about the research study or personal genomic testing. Most respondents perceived the study to have health-related benefits. Nearly all (92%) intended to share their results with physicians, primarily to request specific medical recommendations.

conclusionEarly adopters of personal genomics are prospectively enthusiastic about using genomic profiling information to improve their health, in close consultation with their physicians. This suggests that early users (i.e. through direct-to-consumer companies or research) may follow up with the health care system. Further research should address whether intentions to seek care match actual behaviors.

Indexed as

Community ParticipationGenetic Predisposition to DiseaseGenomicsMotivationPerceptionPrecision MedicineAdolescentAdultAgedFemaleHumansInformation DisseminationMaleMiddle AgedProspective StudiesYoung Adult

Identifiers

PMID21654153
PMCPMC3225236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.